Canaccord Genuity Assumes Lipocine Inc (LPCN) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts LPCN Hot Sheet
Price: $1.68 -0.59%
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 10 | New: 19
Rating Summary:
6 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 10 | New: 19
Join SI Premium – FREE
Canaccord Genuity assumed coverage on Lipocine Inc (NASDAQ: LPCN) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Lipocine Inc click here. For more ratings news on Lipocine Inc click here.
Shares of Lipocine Inc closed at $3.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Starts Smart Parking Ltd (SPZ:AU) at Outperform
- Jefferies Starts Concentra Group Holdings Parent Inc (CON) at Buy
- PesoRama closes $28.4M share offering on TSX Venture Exchange
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
